207 related articles for article (PubMed ID: 31838171)
1. Relative D3 vitamin deficiency and consequent cognitive impairment in an animal model of Alzheimer's disease: Potential involvement of collapsin response mediator protein-2.
Lin FY; Lin YF; Lin YS; Yang CM; Wang CC; Hsiao YH
Neuropharmacology; 2020 Mar; 164():107910. PubMed ID: 31838171
[TBL] [Abstract][Full Text] [Related]
2. Nasal delivery of a CRMP2-derived CBD3 adenovirus improves cognitive function and pathology in APP/PS1 transgenic mice.
Qi B; Yang Y; Cheng Y; Sun D; Wang X; Khanna R; Ju W
Mol Brain; 2020 Apr; 13(1):58. PubMed ID: 32272942
[TBL] [Abstract][Full Text] [Related]
3. Collapsin response mediator protein 5 (CRMP5) causes social deficits and accelerates memory loss in an animal model of Alzheimer's disease.
Lin YS; Lin YF; Chen KC; Yang YK; Hsiao YH
Neuropharmacology; 2019 Oct; 157():107673. PubMed ID: 31233825
[TBL] [Abstract][Full Text] [Related]
4. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-β₂₅₋₃₅ induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2.
Isono T; Yamashita N; Obara M; Araki T; Nakamura F; Kamiya Y; Alkam T; Nitta A; Nabeshima T; Mikoshiba K; Ohshima T; Goshima Y
Neurosci Res; 2013 Nov; 77(3):180-5. PubMed ID: 23994236
[TBL] [Abstract][Full Text] [Related]
6. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis.
Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X
J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456
[TBL] [Abstract][Full Text] [Related]
7. Collapsin response mediator protein 2 (CRMP2) interacts with N-methyl-D-aspartate (NMDA) receptor and Na+/Ca2+ exchanger and regulates their functional activity.
Brustovetsky T; Pellman JJ; Yang XF; Khanna R; Brustovetsky N
J Biol Chem; 2014 Mar; 289(11):7470-82. PubMed ID: 24474686
[TBL] [Abstract][Full Text] [Related]
8. Early Intervention with a Multi-Ingredient Dietary Supplement Improves Mood and Spatial Memory in a Triple Transgenic Mouse Model of Alzheimer's Disease.
Hutton CP; Lemon JA; Sakic B; Rollo CD; Boreham DR; Fahnestock M; Wojtowicz JM; Becker S
J Alzheimers Dis; 2018; 64(3):835-857. PubMed ID: 29914019
[TBL] [Abstract][Full Text] [Related]
9. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway.
Mota SI; Ferreira IL; Valero J; Ferreiro E; Carvalho AL; Oliveira CR; Rego AC
Exp Neurol; 2014 Nov; 261():698-709. PubMed ID: 25128699
[TBL] [Abstract][Full Text] [Related]
10. CRMP2-derived peptide ST2-104 (R9-CBD3) protects SH-SY5Y neuroblastoma cells against Aβ
Ji Y; Hu Y; Ren J; Khanna R; Yao Y; Chen Y; Li Q; Sun L
Chem Biol Interact; 2019 May; 305():28-39. PubMed ID: 30871964
[TBL] [Abstract][Full Text] [Related]
11. Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease.
Shishido H; Kishimoto Y; Kawai N; Toyota Y; Ueno M; Kubota T; Kirino Y; Tamiya T
Neurosci Lett; 2016 Aug; 629():62-67. PubMed ID: 27373531
[TBL] [Abstract][Full Text] [Related]
12. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
[TBL] [Abstract][Full Text] [Related]
13. High Mobility Group Box 1 Ameliorates Cognitive Impairment in the 3×Tg-AD Mouse Model.
Zhang J; Hua XF; Gu J; Chen F; Gu J; Gong CX; Liu F; Dai CL
J Alzheimers Dis; 2020; 74(3):851-864. PubMed ID: 32116254
[TBL] [Abstract][Full Text] [Related]
14. Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice.
Huang HJ; Chen SL; Huang HY; Sun YC; Lee GC; Lee-Chen GJ; Hsieh-Li HM; Su MT
Psychopharmacology (Berl); 2019 Feb; 236(2):763-773. PubMed ID: 30426182
[TBL] [Abstract][Full Text] [Related]
15. Standardized Herbal Formula PM012 Decreases Cognitive Impairment and Promotes Neurogenesis in the 3xTg AD Mouse Model of Alzheimer's Disease.
Ye M; Chung HS; An YH; Lim SJ; Choi W; Yu AR; Kim JS; Kang M; Cho S; Shim I; Bae H
Mol Neurobiol; 2016 Oct; 53(8):5401-12. PubMed ID: 26446019
[TBL] [Abstract][Full Text] [Related]
16. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
[TBL] [Abstract][Full Text] [Related]
17. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
18. The standardized Lycium chinense fruit extract protects against Alzheimer's disease in 3xTg-AD mice.
Ye M; Moon J; Yang J; Hwa Lim H; Bin Hong S; Shim I; Bae H
J Ethnopharmacol; 2015 Aug; 172():85-90. PubMed ID: 26102549
[TBL] [Abstract][Full Text] [Related]
19. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D Improves Neurogenesis and Cognition in a Mouse Model of Alzheimer's Disease.
Morello M; Landel V; Lacassagne E; Baranger K; Annweiler C; Féron F; Millet P
Mol Neurobiol; 2018 Aug; 55(8):6463-6479. PubMed ID: 29318446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
